Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Investigating dopamine D1-D2 receptor heteromer neuron specific mechanisms of psychiatric disorder pathology in human post-mortem striatum

FY 2024-25

Summary
The cause of major depressive disorder (MDD) and the reason why females are two-times more likely to develop MDD compared to males remains unknown. The George Lab has established that activation of dopamine D1-D2 receptor complex (D1-D2R) increased anxiety and depressive-like behaviours and blocking the complex reduced these behaviours in rodent models of depression. Further, adult females have higher-levels of striatal (brain region) D1-D2R expression compared to males which may underlie increased female depression-like susceptibility. Therefore, our goal is to investigate whether D1-D2R levels and their pro-depressive downstream molecules are altered in a sex and cell-type dependent manner in human post-mortem striatum and elevated in patients with a history of MDD. Objective 1: Determine the age of onset and time-course of development of sex-specific differences in D1-D2R expression. This will help decipher the role of D1-D2R and establish when the male/female differences are established. Objective 2: Develop and validate a multiplex immunohistochemistry (mIHC) protocol in naive rat brain-tissue. Cell-type specific D1-D2R expression and its downstream pro-depressive signalling proteins will be analyzed. Fluorescence Resonance Energy Transfer (FRET) will help determine D1-D2R density and receptor-receptor distance within the complex. Objective 3: Conduct mIHC on post-mortem human brain striatum samples from individuals of both sexes with MDD without psychosis and their matched control subjects. Upon validation of mIHC and FRET in rat, cell-type specific expression of D1-D2R and downstream proteins will be evaluated in human samples. Results from this project will aid in defining the role of D1-D2R signalling in MDD etiology for novel anti-depressant development.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530201
Name
Ali Maqdis
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating dopamine D1-D2 receptor heteromer neuron specific mechanisms of psychiatric disorder pathology in human post-mortem striatum
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anxiety; Brain; Depression; Dopamine; Heteromer; Human; Psychiatry; Rat; Sex-Differences; Striatum
Abstract
The cause of major depressive disorder (MDD) and the reason why females are two-times more likely to develop MDD compared to males remains unknown. The George Lab has established that activation of dopamine D1-D2 receptor complex (D1-D2R) increased anxiety and depressive-like behaviours and blocking the complex reduced these behaviours in rodent models of depression. Further, adult females have higher-levels of striatal (brain region) D1-D2R expression compared to males which may underlie increased female depression-like susceptibility. Therefore, our goal is to investigate whether D1-D2R levels and their pro-depressive downstream molecules are altered in a sex and cell-type dependent manner in human post-mortem striatum and elevated in patients with a history of MDD. Objective 1: Determine the age of onset and time-course of development of sex-specific differences in D1-D2R expression. This will help decipher the role of D1-D2R and establish when the male/female differences are established. Objective 2: Develop and validate a multiplex immunohistochemistry (mIHC) protocol in naive rat brain-tissue. Cell-type specific D1-D2R expression and its downstream pro-depressive signalling proteins will be analyzed. Fluorescence Resonance Energy Transfer (FRET) will help determine D1-D2R density and receptor-receptor distance within the complex. Objective 3: Conduct mIHC on post-mortem human brain striatum samples from individuals of both sexes with MDD without psychosis and their matched control subjects. Upon validation of mIHC and FRET in rat, cell-type specific expression of D1-D2R and downstream proteins will be evaluated in human samples. Results from this project will aid in defining the role of D1-D2R signalling in MDD etiology for novel anti-depressant development.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ali, Maqdis
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~